Natera: Q1 Results Reflect Triumphs In Prenatal, Transplant, And Cancer Testing
Seeking Alpha,
Summary Natera reported outstanding Q1 2023 financial results, with revenues soaring to $241.8 million, marking a 24.5…
Summary Natera reported outstanding Q1 2023 financial results, with revenues soaring to $241.8 million, marking a 24.5…
Ben Fangman, MD, and colleagues provide an overview of the use of circulating tumor DNA levels to detect minimal residual…
The ability to interrogate DNA, proteins and other material in the bloodstream for information about cancers, infectious…